KDI 792

Drug Profile

KDI 792

Alternative Names: FK 070; FR 121070

Latest Information Update: 12 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fujisawa
  • Developer Fujisawa; Kissei Pharmaceutical
  • Class Small molecules
  • Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane A2 synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Cerebrovascular disorders; Diabetic neuropathies; Peripheral vascular disorders

Most Recent Events

  • 12 Oct 2006 Discontinued - Clinical-Phase-Unknown for Diabetic neuropathies in Japan (unspecified route)
  • 12 Oct 2006 Discontinued - Phase-II for Cerebrovascular disorders in Japan (unspecified route)
  • 12 Oct 2006 Discontinued - Phase-II for Peripheral vascular disorders in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top